November 2026
Lung cancer can affect anyone with lungs.
That means anyone can get lung cancer. Screening is one of the most powerful tools we have to find it earlier, and more countries are rolling out national screening programmes. But screening is aimed at people at highest risk, so what about everyone else?
Every day, health systems carry out scans that capture part of the lung. These might be routine scans, or they might happen in emergency rooms.
Some of these scans will reveal small lesions called incidental pulmonary nodules (IPNs). Most are harmless, but some are an early sign of lung cancer. With the right processes in place to find, track and manage them, IPNs offer a route to earlier diagnosis for people who fall outside screening programmes, or live where screening isn’t available.
This Lung Cancer Awareness Month, we’re shining a spotlight on IPN management and looking at how health systems can make every incidental finding count.
In this issue:
- Our new implementation toolkit for IPN management programmes, including a framework to assess your health system’s readiness
- Network member Q&A: Dr Joelle Fathi on IPN management in practice
- What’s still to come this month
To stay up to date with our work, please follow us on X, LinkedIn and YouTube. You can also visit our website or email us at networksecretariat@hpolicy.com. |